Stocks analysis

Analysis for MRSH

  • 📈 Growth — 6/30
  • 💰 Profitability — 18/20
  • 🏦 Financial Health — 14/20
  • 💵 Valuation — 12/20
  • ⚠️ Risk — 6/10
Overall Score: 56/100

Summary:


📈 Growth & Financial Trajectory

The 8-quarter trend cannot be assessed from a single Q1 2026 report. Revenue for Q1 2026 is $7.597B and net income attributable to parent is $1.146B, with operating income of $1.754B and net income after tax of $1.186B. The implied operating margin is about 23.1%. However, quarterly cash flow shows negative operating cash flow of -$0.688B, while financing provided $0.114B and investing consumed -$0.104B; exchange movements weighed on cash. Overall trajectory requires additional quarters to confirm growth pattern.

💰 Margins & Cash Flow

The reported operating margin (~23%) indicates solid efficiency given the revenue base. Gross margin data is not disclosed here, but the gap between revenue and expenses yields a positive operating profit. Cash flow shows a negative operating cash flow for the quarter, with a modest financing inflow and investing outflows; free-cash-like strength is not evident in this single period.

🛡️ Balance Sheet & Liquidity

Total assets are $58.56B with liabilities of $43.75B and equity of $14.81B. The current ratio is 1.11x, signaling modest liquidity cushion. Long-term debt stands at $19.55B and total liabilities exceed equity by roughly 2.95x, indicating meaningful leverage but a collective balance sheet with broad asset coverage.

⚠️ Key Drivers & Risks

  • Drivers: Broad risk-management and insurance brokerage demand; global operations support cross-selling and diversification.
  • Risks: High leverage and sensitivity to macro cycles/regulatory shifts could compress margins or heighten funding needs.